Bergeron, M. G., Gagne, N., Desormeaux, A., Tremblay, M., Gourde, P., Omar, R., and Beauchamp, D. (1998, June). Efficacy of a gel formulation to prevent the transmission of patho-gens causing sexually transmitted diseases. Presented at the 12th International Conference on AIDS, Geneva, Switzer-land, Abstract No. 33123.
Bergeron, M. G., Gagne, N., Gourde, P., Perron, S., Tremblay, M., Beauchamp, D., Juhasz, J., and Desormeaux, A. (1996, July). Microbicidal gel to prevent the sexual transmission of HIV. Presented at the 11th International Conference on AIDS, Vancouver, Canada, Abtract No. We.A.512.
Bergeron, M. G., Gagne, N., Harvie, P., Tremblay, M., Beauchamp, D., Juhasz, J., and Desormeaux, A. (1995, February). Incorpo-ration of microbicides into a gel formulation to prevent sexual transmission of HIV in women.Presented at the HIV Infection in Women Conference, Pasadena, California, Abstract No. S48.
Calypool, L. E., Doncel, G. F., Allen, L. B., Keith, K. A., Brazier, A. D., and Buckheit, R. W. (1998, June). Screening and selec-tion of active anti-agents for the development of vaginal micro-bicides. Presented at the 12th International Conference on AIDS, Geneva, Switzerland, Abstract No. 33144.
Carballo-Dieguez, A., and Dolezal, C. (1996, February). Lubricant use for anal sex in men who have sex with men (MSM). Presented at the Eighth Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS: Conference on Advances in AIDS Vaccine Development, Washington, D.C., Abstract No. 89.
Cook, R. L., and Rosenberg, M. J. (1998). Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? A meta-analysis. Sexually Transmitted Diseases, 25, 144–150.
Gross, M., Buchbinder, S. P., Celum, C., Heagerty, P., and Seage, G. R. (1998). Rectal microbicides for U.S. gay men: Are clinical trials needed? Are they feasible? Sexually Transmitted Diseases, 25, 296–302.
Gross, M., Celum, C., Tabet, S., Kelly, C. W., Coletti, A. S., and Chesney, M. A. (in press). Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sexually Transmitted Diseases.
Harbison, M. A., and Manner, S. M. (1989). Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine. Journal of Acquired Immune Deficiency Syndromes, 2, 16–20.
Harrison, C., and Chantler, E. (1998). The effect of nonoxynol-9 and chlorhexidine on HIV and sperm in vitro. International Journal of STD and AIDS, 9, 92–97.
Hays, R. B., Paul, J., Ekstrand, M., Kegeles, S. M., Stall, R., and Coates, T. J. (1997). Actual versus perceived HIV status, sexual behaviors and predictors of unprotected sex among young gay and bisexual men who identify as HIV-negative, HIV-positive, and untested. AIDS, 11, 1495–1502.
Hira, S. K., Feldblum, P. J., Kamanga, J., Mukelabai, G., Weir, S. S., and Thomas, J. C. (1997). Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. International Journal of STD and AIDS, 8, 243–250.
Pauwels, R., and De Clercq, E. (1996). Development of vaginal microbicides for the prevention of heterosexual transmission of HIV. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11, 211–221.
Pinkerton, S. D., and Abramson, P. R. (1997). Effectiveness of condoms in preventing HIV transmission. Social Science and Medicine, 44, 1303–1312.
Roddy, R. E., Aekeng, L., Ryan, K. A., Tamourfe, U., Weir, S. S., and Wong, E. L. (1998). A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. New England Journal of Medicine, 339, 504–510.
Stafford, M. K., Ward, H., Flanagan, A., Rosenstein, I. J., Taylor-Robinson, D., Smith, J. R., Weber, J., and Kitchen, V. S. (1998). Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects. Journal of Acquired Immune Deficiency Syndromes and HumanRetrovirology, 17, 327–331.
Steiner, S., Lemke, A. L., and Roffman, R. A. (1994). Risk behavior for HIV transmission among gay men surveyed in Seattle bars. Public Health Reports, 109, 563–566.
Taylor, C. (1998, June). HIV/STD prevention, topical microbicides and rectal sex. Presented at the 12th International Conference on AIDS, Geneva, Switzerland, Abstract No. 33159.
Van Damme, L., Niruthisard, S., Atisook, R., Boer, K., Dally, L., Laga, M., Lange, J. M., Karam, M., and Perriens, J. H. (1998). Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS, 12, 433–437.
Van de Ven, P., Noble, J., Kippax, S., Prestage, G., Crawford, J., Baxter, D., and Cooper, D. (1997). Gay youth and their precautionary sexual behaviors: The Sydney Men and Sexual Health Study. AIDS Education and Prevention, 9, 395–410.
Watts, C., Thompson, W., and Heise, L. (1998, June). The effective-ness of microbicides for HIV prevention. Presented at the 12th International Conference on AIDS, Geneva, Switzerland, Ab-stract No. 33161.
Weatherburn, P., Hunt, A. J., Davies, P. M., Coxon, A. P. M., and McManus, T. J. (1991). Condom use in a large cohort of homosexually active men in England and Wales. AIDS Care, 3, 31–41.
Wittkowski, K. M., Susser, E., and Dietz, K. (1998). The protective effect of condoms and nonoxynol-9 against HIV infection. American Journal of Public Health, 88, 590–596.